MA31113B1 - Composes complexes de fer/glucides - Google Patents

Composes complexes de fer/glucides

Info

Publication number
MA31113B1
MA31113B1 MA32121A MA32121A MA31113B1 MA 31113 B1 MA31113 B1 MA 31113B1 MA 32121 A MA32121 A MA 32121A MA 32121 A MA32121 A MA 32121A MA 31113 B1 MA31113 B1 MA 31113B1
Authority
MA
Morocco
Prior art keywords
iron
complex compounds
carbohydrate complex
complex compound
compound
Prior art date
Application number
MA32121A
Other languages
Arabic (ar)
English (en)
Inventor
Stefan Reim
Peter Geisser
Original Assignee
Vifor Int Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=38441703&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MA31113(B1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Vifor Int Ag filed Critical Vifor Int Ag
Publication of MA31113B1 publication Critical patent/MA31113B1/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B31/00—Preparation of derivatives of starch
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7135—Compounds containing heavy metals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/26—Iron; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H23/00—Compounds containing boron, silicon, or a metal, e.g. chelates, vitamin B12
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/0006—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid
    • C08B37/0009—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid alpha-D-Glucans, e.g. polydextrose, alternan, glycogen; (alpha-1,4)(alpha-1,6)-D-Glucans; (alpha-1,3)(alpha-1,4)-D-Glucans, e.g. isolichenan or nigeran; (alpha-1,4)-D-Glucans; (alpha-1,3)-D-Glucans, e.g. pseudonigeran; Derivatives thereof
    • C08B37/0021—Dextran, i.e. (alpha-1,4)-D-glucan; Derivatives thereof, e.g. Sephadex, i.e. crosslinked dextran

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Molecular Biology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biochemistry (AREA)
  • Materials Engineering (AREA)
  • Polymers & Plastics (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Genetics & Genomics (AREA)
  • Immunology (AREA)
  • Biotechnology (AREA)
  • Obesity (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Compounds Of Iron (AREA)
  • Carbon And Carbon Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)

Abstract

L'invention concerne un composé complexe de fer/glucides caractérisé par sa teneur en fer (ii). L'invention concerne également des procédés de fabrication d'un composé complexe de fer/glucides et l'utilisation dudit composé pour le traitement d'anémies ferriprives.
MA32121A 2007-01-19 2009-07-27 Composes complexes de fer/glucides MA31113B1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP07100803A EP1947120A1 (fr) 2007-01-19 2007-01-19 Liaisons complexes d'hydrate de carbone de fer
PCT/EP2008/050387 WO2008087135A1 (fr) 2007-01-19 2008-01-15 Composés complexes de fer/glucides

Publications (1)

Publication Number Publication Date
MA31113B1 true MA31113B1 (fr) 2010-01-04

Family

ID=38441703

Family Applications (1)

Application Number Title Priority Date Filing Date
MA32121A MA31113B1 (fr) 2007-01-19 2009-07-27 Composes complexes de fer/glucides

Country Status (25)

Country Link
US (1) US8263564B2 (fr)
EP (2) EP1947120A1 (fr)
JP (1) JP5225289B2 (fr)
KR (1) KR101200992B1 (fr)
CN (1) CN101589064B (fr)
AR (1) AR064786A1 (fr)
AU (1) AU2008206969B2 (fr)
BR (1) BRPI0807037A2 (fr)
CA (1) CA2675117C (fr)
CL (1) CL2008000140A1 (fr)
ES (1) ES2732290T5 (fr)
GT (1) GT200900204A (fr)
HK (1) HK1135417A1 (fr)
IL (1) IL199726A (fr)
MA (1) MA31113B1 (fr)
MX (1) MX2009007695A (fr)
MY (1) MY148299A (fr)
NZ (1) NZ578457A (fr)
PE (1) PE20090187A1 (fr)
RU (1) RU2423122C2 (fr)
SA (1) SA08290017B1 (fr)
TN (1) TN2009000303A1 (fr)
TW (1) TWI388330B (fr)
WO (1) WO2008087135A1 (fr)
ZA (1) ZA200905738B (fr)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2496595A2 (fr) * 2009-11-04 2012-09-12 Symed Labs Limited Procédé de préparation d'un complexe de carboxymaltose ferrique
CN101967205B (zh) * 2010-10-12 2013-04-17 滨州学院 一种β-葡聚糖铁复合物及其制备方法
CN102451185A (zh) * 2010-10-19 2012-05-16 长春纳米生技公司 金属离子纳米簇组合物
WO2012104204A1 (fr) 2011-01-31 2012-08-09 Vifor (International) Ag Composés à base d'un complexe de fer-hydrate de carbone pour la thérapie intraveineuse du paludisme
WO2013056085A1 (fr) 2011-10-13 2013-04-18 Vidasym, Inc. Composition de fibre de fer, sa préparation et ses utilisations
US20150289554A1 (en) * 2012-10-25 2015-10-15 Otc Nutrition Llc Fast Dissolving Solid Calcium Mineral Supplement Compositions and Processing Making
EP2934508B1 (fr) * 2012-12-21 2017-12-06 Vifor (International) AG Liaisons de complexes de fe(iii)-2-oxo-butanediamide pour le traitement et la prophylaxie des carences en fer et des anémies
CA2901018C (fr) * 2013-03-08 2022-05-03 Vidasym, Inc. Compositions complexes a constituant ion metallique-fibre fonctionnelle, leur preparation et leurs utilisations
US20180147238A1 (en) * 2015-05-29 2018-05-31 Sun Pharmaceutical Industries Ltd. Composition of iron sucrose and process for its preparation
US10258647B2 (en) 2015-09-01 2019-04-16 Particle Dynamics International, Llc Iron-polysaccharide complexes and methods for the preparation thereof
RU2625739C1 (ru) * 2016-09-28 2017-07-18 Общество с ограниченной ответственностью Научно-производственное предприятие "Эксорб" Фармакологическая композиция на основе соединений железа
PT3930686T (pt) 2019-02-28 2023-09-04 Renibus Therapeutics Inc Novas composições de ferro e métodos de preparação e utilização das mesmas
CN112156109A (zh) * 2020-09-29 2021-01-01 神奈纳米医药技术(珠海)有限公司 氢氧化铁-糖络合物的制备方法及其应用
RU2763135C1 (ru) * 2021-04-23 2021-12-27 Виктор Павлович Ремез Фармакологическая композиция для лечения железодефицитной анемии
EP4399022A1 (fr) * 2021-09-10 2024-07-17 The European Atomic Energy Community (EURATOM), represented by the European Commission Produit intégré pour le transport, le stockage et/ou la manipulation de lanthanides ou d'actinides et procédé de fabrication
WO2023041957A1 (fr) * 2021-09-16 2023-03-23 Virchow Biotech Private Limited Procédé efficace pour la synthèse de complexes glucidiques de fer (iii)

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1617463A1 (de) * 1965-11-20 1971-04-08 Bayer Ag Verfahren zur Herstellung von injizierbaren kolloidalen Eisenzubereitungen
DE3026868C2 (de) * 1980-07-16 1986-03-13 Laboratorien Hausmann AG, St. Gallen Verfahren zur Herstellung von Eisen(III)hydroxid-Dextran-Komplexen und sie enthaltende pharmazeutische sterile wäßrige Lösung
CA1319612C (fr) 1987-07-02 1993-06-29 Haile Mehansho Supplements mineraux fer-calcium a biodisponibilite amelioree
US4786518A (en) 1987-07-02 1988-11-22 The Procter & Gamble Company Iron mineral supplements
DE3844065A1 (de) † 1988-12-28 1990-07-05 Orgaplan Gmbh Glycosidische eisen-ii- und eisen-iii-komplexzubereitungen und ihre verwendung
DK172860B1 (da) * 1998-03-25 1999-08-16 Pharmacosmos Holding As Jerndextranforbindelse til anvendelse som komponent i et terapeutisk middel til forebyggelse af eller behandling af jernman
US6461651B1 (en) * 2000-09-26 2002-10-08 General Mills, Inc. Sodium-free iron complex for food fortification
RU2198665C1 (ru) * 2001-12-27 2003-02-20 Общество с ограниченной ответственностью Фирма "А-БИО" Способ получения железосодержащего лекарственного средства
DE10249552A1 (de) * 2002-10-23 2004-05-13 Vifor (International) Ag Wasserlösliche Eisen-Kohlenhydrat-Komplexe, deren Herstellung und diese enthaltende Arzneimittel
US7964568B2 (en) * 2003-05-30 2011-06-21 Chromaceutical Advanced Technologies, Inc. Synthesis of high molecular weight iron-saccharidic complexes
WO2005116046A1 (fr) * 2004-05-24 2005-12-08 Cilag Ag Procede de production d'un complexe fer-saccharose
CN1985489B (zh) 2004-07-09 2012-05-09 艾利森电话股份有限公司 在多媒体通信系统中提供不同服务的方法和装置
CN1739531A (zh) * 2005-09-12 2006-03-01 南京生命能科技开发有限公司 一种治疗缺铁性贫血的蔗糖铁注射液及其制备方法
CN101215338B (zh) * 2007-01-05 2010-09-15 庄茅 异麦芽低聚糖铁及其制备方法
CN101390923A (zh) * 2007-09-21 2009-03-25 韩泳平 一种红景天多糖铁复方制剂的制备及应用

Also Published As

Publication number Publication date
MX2009007695A (es) 2009-07-29
WO2008087135A1 (fr) 2008-07-24
TWI388330B (zh) 2013-03-11
US20100035830A1 (en) 2010-02-11
JP5225289B2 (ja) 2013-07-03
AU2008206969A1 (en) 2008-07-24
US8263564B2 (en) 2012-09-11
SA08290017B1 (ar) 2011-09-13
EP2111416B2 (fr) 2022-03-30
EP2111416B1 (fr) 2019-05-15
RU2423122C2 (ru) 2011-07-10
ES2732290T3 (es) 2019-11-21
HK1135417A1 (en) 2010-06-04
JP2010516828A (ja) 2010-05-20
EP1947120A1 (fr) 2008-07-23
AU2008206969B2 (en) 2012-12-06
KR20090102861A (ko) 2009-09-30
EP2111416A1 (fr) 2009-10-28
TW200835511A (en) 2008-09-01
AR064786A1 (es) 2009-04-22
KR101200992B1 (ko) 2012-11-13
ES2732290T5 (es) 2022-06-07
IL199726A (en) 2014-05-28
CA2675117C (fr) 2014-03-25
BRPI0807037A2 (pt) 2014-04-22
TN2009000303A1 (en) 2010-12-31
CL2008000140A1 (es) 2008-05-16
NZ578457A (en) 2011-08-26
RU2009131464A (ru) 2011-03-10
CA2675117A1 (fr) 2008-07-24
PE20090187A1 (es) 2009-03-15
MY148299A (en) 2013-03-29
CN101589064B (zh) 2014-01-29
CN101589064A (zh) 2009-11-25
GT200900204A (es) 2010-07-22
ZA200905738B (en) 2010-05-26
IL199726A0 (en) 2010-04-15

Similar Documents

Publication Publication Date Title
MA31113B1 (fr) Composes complexes de fer/glucides
FR21C1064I2 (fr) Compositions et procedes de traitement de troubles impliquant une proliferation cellulaire
AR110313A2 (es) Derivados de tiazol-2-il-pirrolidina
NZ596583A (en) Substituted dihydropyrazolones for treating cardiovascular and haematological diseases
MX2007014172A (es) Procedimiento para la produccion de 4-bifenililacetidina-2-onas fenolicos.
WO2007085895A3 (fr) Inhibiteurs fap
MX2009011456A (es) Aumento de la productividad de las plantas por combinacion de agentes quimicos con modificaciones transgenicas.
SG170772A1 (en) Salts of 4-methyl-n-[3-(4-methyl-imidazol-1-yl)-5-trifluoromethyl- phenyl]-3-(4-pyridin-3-yl-pyrimidin-2-ylamino)-benzamide
MX2009004986A (es) Metodos de tratamiento de anemia hemolitica.
ATE541571T1 (de) Diarylhydantoin-verbindung
MY151047A (en) Iron (iii)-carbohydrate based phosphate adsorbent
TW200626068A (en) Active compounds for seed treatment
WO2007035629A3 (fr) Inhibiteurs de dipeptidylpeptidase
MXPA05012680A (es) Indoles novedosos de 3-azufre sustituidos.
NO20080129L (no) Fremgangsmate for fremstilling av dihydrokinazoliner
PL1891004T3 (pl) Pentafluorosulfanylo-podstawiony związek i jego zastosowanie do wytwarzania środków leczniczych
MX2010003365A (es) Derivados de tiazol para el tratamiento de cancer.
TN2011000279A1 (en) Novel pyrazole -4-n-alkoxycarboxamides as microbiocides
DE602007010664D1 (de) P53 aktivierende benzoylharnstoff- und benzoylthioharnstoff-verbindungen
MX2009005935A (es) Compuestos biciclicos y su uso como anti-diabeticos.
WO2009016381A3 (fr) Charbons
MX2007006179A (es) Tetrahidrocarbazoles como agentes activos para inhibir la produccion del factor de crecimiento endotelial vascular por control de la traduccion.
TW200621766A (en) Substituted hydantoins
NO20070608L (no) Anvendelse av 2-tio-3,5-dicyano-4-fenyl-6-aminopyridiner ved behandling av kvalme og oppkast
TW200700071A (en) Novel use